NCT02382458

Brief Summary

Diet plays a central role in the regulation of chronic inflammation. However, until the investigators developed the dietary inflammatory index (DII) there had been no scientifically valid way to relate what individuals eat to the capacity of foods consumed to modulate inflammation. The DII provides a tool that will form the basis of a counseling/instructional system aimed at helping patients and their providers to control chronic, systemic inflammation by improving the diet with specific, actionable dietary recommendations, counseling, and expert instruction. The goal of this study is to test the applicability of a DII mobile tool and associated counseling measures in clinical practice.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
97

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 13, 2015

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 6, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2015

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2017

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2017

Completed
Last Updated

April 18, 2019

Status Verified

April 1, 2019

Enrollment Period

1.8 years

First QC Date

February 13, 2015

Last Update Submit

April 16, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Markers of inflammation assessed via blood samples

    C-reactive protein

    12 weeks

Secondary Outcomes (4)

  • Changes in body weight assessed via digital scales

    52 weeks

  • Changes in dietary intake assessed via three 24-hour dietary recalls

    52 weeks

  • Markers of inflammation assessed via blood samples

    52 weeks

  • Changes in body composition assessed via DXA

    52 weeks

Study Arms (2)

Lifestyle intervention

EXPERIMENTAL

Participants will receive a year-long comprehensive, dietary, exercise, and stress management intervention. They will be asked to bring a partner of their choosing with them for support. The intervention will include a behavioral program to reduce inflammation.

Behavioral: Behavioral program to reduce inflammation

Information intervention

ACTIVE COMPARATOR

Participants will receive a year-long intervention that will involve receiving weekly (for the first 3 months) and then monthly (for the following 9 months) newsletters on cancer prevention and control (via e-mail or mail) that will provide the participant with information about cancer prevention and control strategies.

Behavioral: Newsletters on cancer prevention and control

Interventions

E-mailed or mailed newsletters that provide information on how to prevent cancer

Information intervention

Group classes which will provide participants with information on achieving a healthy diet, increase physical activity, and manage stress

Lifestyle intervention

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Are actively engaged as patients in the medical practices of University Specialty Clinics (under the direction of Dr. Victor Hirth) or Eau Claire Cooperative Health Care System (under the direction of Dr. Stuart Hamilton) or has physician consent
  • Are ≥21 years of age;
  • Are willing and able to participate fully in the study for a period of one year; and
  • Are able to obtain travel to and from the intervention classes at the designated time.

You may not qualify if:

  • Serious, unstable co-morbidity that would make participation in a diet and physical activity intervention difficult or risky including renal disease retinopathy, peripheral vascular disease or neuropathy;
  • Any medications that are known to influence CRP levels such as chronic steroid (e.g., prednisone) use;
  • Diagnoses of congestive heart failure, chronic renal failure, chronic liver disease (including alcoholic cirrhosis), cancer within the past year (except for non-melanoma skin cancer);
  • Actively receiving cancer treatment;
  • Have had any major surgeries in the past 3 months;
  • Poor performance status according to the World Health Organization definitions (i.e., Level 3: symptomatic, \>50% in bed, capable of only limited self-care; or Level 4: bedbound); or
  • Life expectancy \<3 years, on hospice, nursing home or other institutionalized care.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of South Carolina

Columbia, South Carolina, 29208, United States

Location

Related Publications (3)

  • Wirth MD, Turner-McGrievy G, Shivappa N, Murphy EA, Hebert JR. Interaction between Meal-timing and Dietary Inflammatory Potential: Association with Cardiometabolic Endpoints in a 3-month Prospective Analysis. J Nutr. 2023 Oct 28;153(12):3555-64. doi: 10.1016/j.tjnut.2023.10.023. Online ahead of print.

  • Wirth MD, Jessup A, Turner-McGrievy G, Shivappa N, Hurley TG, Hebert JR. Changes in dietary inflammatory potential predict changes in sleep quality metrics, but not sleep duration. Sleep. 2020 Nov 12;43(11):zsaa093. doi: 10.1093/sleep/zsaa093.

  • Turner-McGrievy GM, Wirth MD, Shivappa N, Dunn CG, Crimarco A, Hurley TG, West DS, Hussey JR, Hebert JR. Impact of a 12-month Inflammation Management Intervention on the Dietary Inflammatory Index, inflammation, and lipids. Clin Nutr ESPEN. 2019 Apr;30:42-51. doi: 10.1016/j.clnesp.2019.02.008. Epub 2019 Mar 1.

MeSH Terms

Conditions

Inflammation

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Brie Turner-McGrievy

    University of South Carolina

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 13, 2015

First Posted

March 6, 2015

Study Start

May 1, 2015

Primary Completion

February 28, 2017

Study Completion

December 31, 2017

Last Updated

April 18, 2019

Record last verified: 2019-04

Locations